The store will not work correctly when cookies are disabled.
N-Benzyl-2-(3-trifluoromethyl-phenoxy)-nicotinamide
ID: ALA168121
PubChem CID: 14555265
Max Phase: Preclinical
Molecular Formula: C20H15F3N2O2
Molecular Weight: 372.35
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(NCc1ccccc1)c1cccnc1Oc1cccc(C(F)(F)F)c1
Standard InChI: InChI=1S/C20H15F3N2O2/c21-20(22,23)15-8-4-9-16(12-15)27-19-17(10-5-11-24-19)18(26)25-13-14-6-2-1-3-7-14/h1-12H,13H2,(H,25,26)
Standard InChI Key: UNBQKBYWCORREK-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
-0.9708 -2.6667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9708 -2.0667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6000 -4.7542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4500 -1.7625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0792 -4.4625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4458 -2.9667 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.0667 -2.0542 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.4875 -2.9667 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0750 -3.8625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4458 -3.5667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4583 -1.1625 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.6042 -5.3542 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.1167 -4.4542 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
0.1792 -5.1875 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
0.5875 -1.7542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4875 -1.7667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1125 -2.0542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4458 -4.7667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9625 -4.4667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0083 -2.6667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9625 -3.8667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1125 -2.6542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6250 -1.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0083 -2.0667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1417 -2.0417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6292 -2.9500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1500 -2.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 5 1 0
4 2 1 0
5 9 2 0
6 1 1 0
7 4 1 0
8 1 2 0
9 10 1 0
10 6 1 0
11 4 2 0
12 3 1 0
13 3 1 0
14 3 1 0
15 7 1 0
16 2 2 0
17 15 1 0
18 19 2 0
19 21 1 0
20 8 1 0
21 10 2 0
22 17 2 0
23 17 1 0
24 20 2 0
25 23 2 0
26 22 1 0
27 25 1 0
16 24 1 0
18 5 1 0
26 27 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 372.35 | Molecular Weight (Monoisotopic): 372.1086 | AlogP: 4.82 | #Rotatable Bonds: 5 |
Polar Surface Area: 51.22 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.92 | CX Basic pKa: 1.71 | CX LogP: 4.53 | CX LogD: 4.53 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.70 | Np Likeness Score: -1.74 |
References
1. Vinick FJ, Saccomano NA, Koe BK, Nielsen JA, Williams IH, Thadeio PF, Jung S, Meltz M, Johnson J, Lebel LA.. (1991) Nicotinamide ethers: novel inhibitors of calcium-independent phosphodiesterase and [3H]rolipram binding., 34 (1): [PMID:1825116] [10.1021/jm00105a015] |